Tuo Hu

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 7

Top Topics

Squamous Cell Carcinoma

Prognostic Factors

Bioinformatics Analysis

Top Venues

Journal of clinical medicine

Cancer discovery

This page only lists publications with an associated author ORCID identifier.

Publications

Chunbo He, Dezhen Wang, Surendra K Shukla, Tuo Hu, Ravi Thakur, Xiao Fu, Ryan J King, Sai Sundeep Kollala, Kuldeep S Attri, Divya Murthy, Nina V Chaika, Yuki Fujii, Daisy Gonzalez, Camila G Pacheco, Yudong Qiu, Pankaj K Singh, Jason W Locasale, Kamiya Mehla
Vitamin B6 competition in the tumor microenvironment hampers antitumor functions of NK cells. Cancer discovery (2023)
Guan-Zhan Liang, Xiao-Feng Wen, Yi-Wen Song, Zong-Jin Zhang, Jing Chen, Yong-Le Chen, Wei-Dong Pan, Xiao-Wen He, Tuo Hu, Zhen-Yu Xian
Construction and Validation of a Novel Prognosis Model in Colon Cancer Based on Cuproptosis-Related Long Non-Coding RNAs. Journal of clinical medicine 12 (4) (2023)
Guan-Zhan Liang, Xiao-Feng Wen, Yi-Wen Song, Zong-Jin Zhang, Jing Chen, Yong-Le Chen, Wei-Dong Pan, Xiao-Wen He, Tuo Hu, Zhen-Yu Xian
Construction and Validation of a Novel Prognosis Model in Colon Cancer Based on Cuproptosis-Related Long Non-Coding RNAs. Journal of clinical medicine 12 (4) (2023)
Guan-Zhan Liang, Xiao-Feng Wen, Yi-Wen Song, Zong-Jin Zhang, Jing Chen, Yong-Le Chen, Wei-Dong Pan, Xiao-Wen He, Tuo Hu, Zhen-Yu Xian
Construction and Validation of a Novel Prognosis Model in Colon Cancer Based on Cuproptosis-Related Long Non-Coding RNAs. Journal of clinical medicine 12 (4) (2023)
Jiancong Xie, Tai-Wei Mo, Ruibing Li, Hao Zhang, Guanzhan Liang, Tao Ma, Jing Chen, Hanlin Xie, Xiaofeng Wen, Tuo Hu, Zhen-Yu Xian, Wei-Dong Pan
The m 7 G Reader NCBP2 Promotes Pancreatic Cancer Progression by Upregulating MAPK/ERK Signaling. Cancers 15 (22) (2023)
Nina Geng, Tuo Hu, Chunbo He
Identification of DDX60 as a Regulator of MHC-I Class Molecules in Colorectal Cancer. Biomedicines 10 (12) (2022)
Nina Geng, Tuo Hu, Chunbo He
Identification of DDX60 as a Regulator of MHC-I Class Molecules in Colorectal Cancer. Biomedicines 10 (12) (2022)